The warning comes following the death of a preterm infant who was administered a probiotic formulated with live bacterium.
Your search for evid returned 4583 results
Consistent benefits seen for White and Asian populations and consistent lack of benefits seen in Black populations.
NurOwn consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors.
Higher major pathological response seen for patients with resectable NSCLC treated with combo versus durvalumab alone.
High treatment success rate observed for vaginal and cesarean births across all bleeding causes.
No significant reduction seen in percent of patients with urgent care or emergency department visits or hospitalization.
Review and meta-analysis show improvements in functional exercise capacity vs standard of care.
Molnupiravir and nirmatrelvir-ritonavir combination therapy should be considered for patients within 5 days of symptom onset.
Screening with blood pressure measurements has substantial net benefits and is recommended throughout pregnancy.
Combination of a patch and fast-acting nicotine replacement therapy also effective.